Critical Actions in Emergency Medicine: Timely Diagnosis and Treatment of CAR-T and Bispecific Antibody–Related AEs in Multiple Myeloma

Review strategies for emergency medicine team screening and management of patients with multiple myeloma receiving CAR T-cell therapy or bispecific antibodies who present to the emergency department for care. Review a downloadable slideset, a CME/CE-certified on-demand webcast, and an expert commentary.

Share

Program Content

Activities

CAR T and Bispecific AEs in MM
Critical Actions in Emergency Medicine: Timely Diagnosis and Treatment of CAR T-Cell‒ and Bispecific Antibody‒Related AEs in Multiple Myeloma
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: January 19, 2024

Activities

AEs in MM
Critical Actions in Emergency Medicine: Timely Diagnosis and Treatment of CAR-T and Bispecific Antibody–Related AEs in Multiple Myeloma
Video
Congratulations: You achieved a completion on 04/09/2022

Released: March 01, 2024

Expires: February 28, 2025

Activities

AEs With CAR T-Cell and Bispecific Antibody Tx in MM
Thinking Through Key Considerations for Emergency Medical Professionals on the Management of Patients With Myeloma Receiving CAR T-Cell Therapy or Bispecific Antibodies
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 22, 2024

Expires: May 21, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an education grant from Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC